Celltrion Announces Commercial Availability of ZYMFENTRA™ (infliximab-dyyb)
Merck to Buy Harpoon Therapeutics for $680 Million
Regeneron Sues Formycon AG for Proposed Biosimilar of EYLEA in West Virginia District Court
FDA Approves VABYSMO (faricimab) for Retinal Vein Occlusion
Sandoz Receives FDA Approval for Tyruko® (natalizumab-sztn), the First and Only FDA-Approved Biosimilar for Relapsing Forms of Multiple Sclerosis
Amgen Files BPCIA Complaint Against Sandoz Regarding Denosumab
